Association between the plasminogen activator inhibitor-1 4G/5G polymorphism and venous thrombosis
Date
2007Author
Tsantes, Argirio E.

Rapti, E.
Mantzios, Georgios P.
Kapsimali, Violetta
Travlou, Anthi S.
Source
Thrombosis and haemostasisVolume
97Issue
6Pages
907-913Google Scholar check
Keyword(s):
Metadata
Show full item recordAbstract
The effect of the 675 insertion/deletion (4G/5G) polymorphism of plasminogen activator inhibitor-1 (PAI-1) gene on the risk of venous thromboembolism (VTE) remains controversial. In this study, we performed a meta-analysis of published data regarding this issue. A comprehensive electronic search was carried out up until September 2006.A total of 22 articles were included in the analysis that was performed using random effects models. Eighteen papers, concerning patients without another known risk factor, comprised 2,644 cases and 3,739 controls. The alleles contrast (4G vs. 5G allele) yielded a statistically significant odds ratio (OR) of 1.153 (95% confidence interval [CI]: 1.068-1.246). In a sub-analysis of five studies that included 256 cases with another genetic risk factor and 147 controls, the combined per-allele OR was still significant (OR: 1.833,95% CI: 1.325-2.536). On the contrary, the analysis of five studies regarding cases with a non-genetic risk factor for VTE (antiphospholipid antibody syndrome, Behcet disease) provided insignificant results in all aspects. There was no evidence for heterogeneity and publication bias in all analyses. Based on our findings, the 4G allele appears to increase the risk of venous thrombosis, particularly in subjects with other genetic thrombophilic defects. Recommendation for detection of this polymorphism in evaluating thrombophilia in such patients might be considered. © 2007 Schattauer GmbH, Stuttgart.
Collections
Cite as
Related items
Showing items related by title, author, creator and subject.
-
Article
Sequence variations in the FII, FV, F13A1, FGB and PAI-1 genes are associated with differences in myocardial perfusion
Satra, Maria; Samara, Maria; Wozniak, Greta; Tzavara, Chara; Kontos, Angelos; Valotassiou, Varvara; Vamvakopoulos, Nikolaos K.; Tsougos, Ioannis; Aleporou-Marinou, Vassiliki; Patrinos, George P.; Kollia, Panagoula; Georgoulias, Panagiotis (2011)Aims: Coronary artery disease (CAD) is a significant cause of morbidity and mortality in modern societies. The association between genetic markers and CAD is still poorly understood. In this study, we evaluated the effect ...
-
Article
The cypriot and Iranian National Mutation Frequency Databases.
Kleanthous, Marios; Patsalis, Philippos C.; Drousiotou, Anthi; Motazacker, M.; Christodoulou, Kyproula; Cariolou, Marios A.; Baysal, E.; Khrizi, K.; Moghimi, B.; Pourfarzad, F.; van Baal, S.; Constantinou-Deltas, Constantinos D.; Najmabadi, H.; Patrinos, G. P. (2006)The National Mutation Frequency Databases are continuously updated mutation depositories, which contain extensive information over the described genetic heterogeneity of an ethnic group or population. Here, we report the ...
-
Article
The impact of human allelic variation on HIV-1 disease.
Anastassopoulou, C. G.; Kostrikis, Leontios G. (2003)Human allelic variants influence the susceptibility to HIV-1 infection and/or the subsequent rates of disease progression towards AIDS that average ten years, although they vary greatly among infected subjects. In this ...